miCure Therapeutics is a leading-edge biotech company established in September 2013 in the Science Park of Ness Ziona, Israel. The company is focused on micro-RNA therapeutics and diagnostics for the central nervous system.

miCure obtained an exclusive worldwide license from Yeda Research & Development Company Ltd. to develop products based on technologies emanating from the laboratories of Prof. Alon Chen and Dr. Eran Hornstein of the Weizmann Institute of Science in Rehovot, Israel. The company secured a two million dollar seed investment from private investors.